SAFETY OF INACTIVATED POLYMER-SUBUNIT THREE VALENCE INFLUENZA VACCINE. POSTREGISTRATIONAL OBSERVATION

SAFETY OF INACTIVATED POLYMER-SUBUNIT THREE VALENCE INFLUENZA VACCINE. POSTREGISTRATIONAL OBSERVATION

Show other versions (1)

<em>Clinical trial for polymer-subunit trivalent influenza vaccine Grippol plus reactogenicity assessment in 153 children aged 3–17 years old was conducted in the frames of post-registration studies. Prior to the vaccination the written informed agreement was signed by every participant’ paren...

Full description

Bibliographic Details
Main Authors:	S.M. Kharit, E.P. Nacharova, T.V. Chernyaeva
Format:	Article
Language:	English
Published:	"Paediatrician" Publishers LLC 2009-01-01
Series:	Voprosy Sovremennoj Pediatrii
Online Access:	http://vsp.spr-journal.ru:80/jour/article/view/1141

Similar Items

SAFETY OF INACTIVATED POLYMER-SUBUNIT THREE VALENCE INFLUENZA VACCINE. POSTREGISTRATIONAL OBSERVATION
by: S.M. Kharit, et al.
Published: (2009-07-01)

VACCINATION OF CHILDREN AGAINST MEASLES, PAROTIDITIS AND VITAMINOTHERAPY
by: S.M. Kharit, et al.
Published: (2007-12-01)

VACCINATION OF CHILDREN AGAINST MEASLES, PAROTIDITIS AND VITAMINOTHERAPY
by: S.M. Kharit, et al.
Published: (2007-12-01)

Comparative Assessment of Reactogenicity and Immunogenicity of Commercial Influenza Inactivated Vaccines: Polymer-Subunit Grippol plus, Subunit Influvac, Split Vaccine Waxigrip
by: S. M. Kharit, et al.
Published: (2017-04-01)

SAFETY AND EFFICIENCY OF INACTIVATED OF SUBUNIT INFLUENZA VACCINE AT MASS VACCINATION OF CHILDREN
by: Yu.Z. Gendon
Published: (2007-09-01)

SAFETY AND EFFICIENCY OF INACTIVATED OF SUBUNIT INFLUENZA VACCINE AT MASS VACCINATION OF CHILDREN
by: Yu.Z. Gendon
Published: (2007-01-01)

EVALUATION OF EPIDEMIOLOGIC EFFECTIVENESS OF INFLUENZA INACTIVATED POLYMER-SUBUNIT VACCINE IN SCHOOLCHILDREN
by: T.N. Il'ina
Published: (2009-01-01)

EVALUATION OF EPIDEMIOLOGIC EFFECTIVENESS OF INFLUENZA INACTIVATED POLYMER-SUBUNIT VACCINE IN SCHOOLCHILDREN
by: T.N. Il'ina
Published: (2009-09-01)

SAFETY OF CELL-DERIVED SUBUNIT ADJUVANTED INFLUENZA VACCINE FOR CHILDREN VACCINATION: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
by: S.M. Kharit, et al.
Published: (2010-07-01)

SAFETY OF CELL-DERIVED SUBUNIT ADJUVANTED INFLUENZA VACCINE FOR CHILDREN VACCINATION: DOUBLE-BLIND RANDOMIZED CLINICAL TRIAL
by: S.M. Kharit, et al.
Published: (2010-01-01)

RE-VACCINATION OF CHILDREN OVER 1,5 YEARS OLD AGAINST DIPHTHERIA, PERTUSSIS, TETANUS, POLIOMYELITIS AND HEMOPHILIC INFECTION
by: S.M. Kharit, et al.
Published: (2009-01-01)

RE-VACCINATION OF CHILDREN OVER 1,5 YEARS OLD AGAINST DIPHTHERIA, PERTUSSIS, TETANUS, POLIOMYELITIS AND HEMOPHILIC INFECTION
by: S.M. Kharit, et al.
Published: (2009-11-01)

Immunogenicity and safety of a trivalent inactivated influenza vaccine
by: Eddy Fadlyana, et al.
Published: (2011-02-01)

Immunogenicity and safety of subunit influenza vaccines in pregnant women
by: Mikhail P. Kostinov, et al.
Published: (2018-04-01)

Studies on inactivated influenza vaccines
by: Forsyth, Jocelyn Robert Lane
Published: (2020)

Difficulties in Differential Diagnosis of Post-Vaccination Period. Practical Examples
by: E. P. Nacharova, et al.
Published: (2017-12-01)

EFFICIENCY AND SAFETY OF USING PIDOTIMOD IN VACCINATED RISK GROUP CHILDREN
by: A. A. Ruleva, et al.
Published: (2013-01-01)

Development of chicken anemia virus subunit and inactivated vaccine
by: Shen sinying, et al.
Published: (2014)

Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines
by: Saranya Sridhar, et al.
Published: (2015-04-01)

Safety of Inactivated Influenza Vaccine in Patients with Egg Allergy in Kurdistan Province, Iran
by: Sima TOZANDEHJANI, et al.
Published: (2019-04-01)

SAFETY ASSESSMENT OF TWO SUBUNIT INFLUENZA VACCINES IN CHILDREN WITH A BURDENED ALLERGOANAMNEZ
by: M. G. Galitskaya, et al.
Published: (2015-08-01)

REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF DOMESTIC FLU-M INACTIVATED SPLIT INFLUENZA VACCINE FOR THE IMMUNIZATION OF ADULTS AGED BETWEEN 18 AND 60
by: I. V. Feldblyum, et al.
Published: (2018-10-01)

Convulsive syndrome in the post-vaccination period: is there a connection with the vaccine?
by: E. P. Nacharova, et al.
Published: (2021-01-01)

Correction: Offline Digital Education for Postregistration Health Professions: Systematic Review and Meta-Analysis by the Digital Health Education Collaboration
by: Posadzki, Pawel, et al.
Published: (2020-06-01)

Safety and immunogenicity of an MF59™-adjuvanted subunit influenza vaccine in elderly Chinese subjects
by: Pellegrini Michele, et al.
Published: (2008-02-01)

Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo.
by: Maaike Stoel, et al.
Published: (2015-01-01)

MF59-adjuvanted seasonal trivalent inactivated influenza vaccine: Safety and immunogenicity in young children at risk of influenza complications
by: Sanjay S. Patel, et al.
Published: (2019-08-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
by: D. V. Bukhanova, et al.
Published: (2018-07-01)

Clinical Study of Safety and Efficacy of a Polymer-Subunit Adjuvant Influenza Vaccine Applied in Combination with an Immune Modulator in People Aged 60 and Over
by: V. V. Romanenko, et al.
Published: (2016-10-01)

An Improved Inactivated Influenza Vaccine with Enhanced Cross Protection
by: Yawei Ni, et al.
Published: (2018-08-01)

Studies on the development of adjuvants and inactivated vaccines of avian influenza
by: DAI, SHI-YUAN, et al.
Published: (1993)

Adjuvant Selection for Influenza and RSV Prefusion Subunit Vaccines
by: Ariel Isaacs, et al.
Published: (2021-01-01)

SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS
by: D. V. Bukhanova, et al.
Published: (2018-07-01)

The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan.
by: Shin-Yu Lin, et al.
Published: (2013-01-01)

Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes.
by: Theone C Kon, et al.
Published: (2016-01-01)

The results of clinical trial on immunogenicity of adjuvanted quadrivalent inactivated subunit influenza vaccine Grippol Quadrivalent in pediatric population 6 to 17 years old
by: Kovtun O.P., et al.
Published: (2020-01-01)

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
by: Bouveret Nancy, et al.
Published: (2010-03-01)

Immunogenicity of Concentrated and Purified Inactivated Avian Influenza Vaccine Formulation
by: A. Nazari, et al.
Published: (2018-12-01)

Cross-Protective Immune Responses Induced by Sequential Influenza Virus Infection and by Sequential Vaccination With Inactivated Influenza Vaccines
by: Wei Dong, et al.
Published: (2018-10-01)

Randomized, placebo-controlled trial on safety and efficacy of inactivated influenza vaccination of pregnant women in preventing illness in their infants
by: S. Madhi, et al.
Published: (2014-04-01)